BioSpace News Archive

BioMidwest

Neogen Announces 4-for-3 Stock Split

The stock split will be effected in the form of new common stock being issued on Dec. 29, 2017, to shareholders of record as of the close of business on Dec. 18, 2017.

December 8, 2017
·
2 min read
BioForest

Otoharmonics’ Levo Tinnitus System Shown to Have Better Outcomes Than Current Standard of Care

The Levo System has been cleared by the FDA for sales in the U.S. and is cleared for sale in Canada and Europe through CE Mark.

December 8, 2017
·
3 min read
Business

Guided Therapeutics Signs Preliminary License Agreement With Turkish Distribution Partner Based on Ministry of Health Support for the LuViva Advanced Cervical Scan

In return for the license and manufacturing rights for Cervical Guides in Turkey, GTHP will receive fees totaling $3,000,000 in 2018.

December 8, 2017
·
4 min read
Pharm Country

Fox Chase Cancer Center Researchers Seek Breast Cancer Biomarkers That Indicate Immunotherapy Responsiveness

A small, but significant proportion of patients with invasive breast cancer have at least one of three biomarkers linked to ICB therapy, suggesting a role for such treatment for certain breast cancers, a new study shows.

December 8, 2017
·
1 min read
Business

Fennec Announces Pricing of Public Offering

The offering is expected to close on December 12, 2017, subject to customary closing conditions.

December 8, 2017
·
4 min read
Business

Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology

Under the deal, OAHL will invest up to $2.2 million in tranches to purchase shares of our Capnia subsidiary and as a result of this investment, Capnia will no longer be a wholly-owned subsidiary of Soleno.

December 8, 2017
·
3 min read
Business

Genovis Signs Distribution Agreement in India

Genovis is continuing to expand in Asia and has signed a distribution agreement with Allianz Bioinnovation for the Indian market.

December 8, 2017
·
2 min read
Policy

Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

At the meeting, the panel voted 15 to 0 that patients with interstitial cystitis and patients with bladder pain syndrome should be combined in clinical trials.

December 8, 2017
·
6 min read